Ardent Health Q3 EPS Estimate Lowered by Leerink Partnrs

Key Points

• Leerink Partners has reduced their Q3 2025 EPS forecast for Ardent Health from $0.81 to $0.36, while the consensus for the full-year earnings is $1.23 per share.
• The company reported a Q2 EPS of $0.52, exceeding analysts' expectations of $0.30, with revenues of $1.65 billion against predictions of $1.54 billion.
• Several investment ratings have been issued recently, with Bank of America downgrading Ardent Health stock to "underperform" while other firms maintain "buy" or "overweight" ratings.

Ardent Health, Inc. (NYSE:ARDT - Free Report) - Equities research analysts at Leerink Partnrs cut their Q3 2025 earnings per share estimates for shares of Ardent Health in a report released on Wednesday, August 6th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.36 per share for the quarter, down from their prior forecast of $0.81. The consensus estimate for Ardent Health's current full-year earnings is $1.23 per share.

Several other equities analysts also recently commented on ARDT. Stephens reaffirmed an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. JPMorgan Chase & Co. cut their target price on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a research note on Monday. Bank of America cut Ardent Health from a "neutral" rating to an "underperform" rating and reduced their target price for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health in a report on Thursday, May 15th. Finally, Guggenheim raised their target price on Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.56.

Ardent Health Trading Down 1.5%

Shares of Ardent Health stock traded down $0.19 during trading on Monday, reaching $12.49. 77,991 shares of the company were exchanged, compared to its average volume of 405,129. Ardent Health has a twelve month low of $10.10 and a twelve month high of $20.72. The business has a 50-day moving average price of $12.55 and a 200-day moving average price of $13.43. The firm has a market capitalization of $1.79 billion and a price-to-earnings ratio of 6.90. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.54 billion.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. bought a new stake in Ardent Health in the fourth quarter worth approximately $27,000. CWM LLC lifted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock valued at $30,000 after buying an additional 2,001 shares during the last quarter. Morse Asset Management Inc purchased a new position in shares of Ardent Health during the 1st quarter valued at $36,000. Deutsche Bank AG lifted its position in shares of Ardent Health by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after buying an additional 2,654 shares during the last quarter. Finally, Quarry LP lifted its position in shares of Ardent Health by 1,519.4% during the 1st quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after buying an additional 4,710 shares during the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.